Cervical transposition test using Hegar dilator at oestrus as a tool to select ewes for transcervical embryo collection.

This study evaluated the cervical transposition method as a tool to select ewes for embryo collection by transcervical route. Adult Santa Inês ewes (n = 50) received Day 0 protocol for superovulation treatments. The cervix transposition test was performed both at oestrus and at the embryo collection time. The latter was preceded by hormonal cervical dilation. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 85.7%, 66.6%, 85.7%, 66.6% and 80.0%, respectively. The kappa index yielded a moderate score (κ = 0.52). In conclusion, the high sensitivity and accuracy indicate that the cervical transposition test is a screening option to select ewes for embryo collection by transcervical route.

Treatment of a periarticular tibial fracture in a foal with a hybrid external fixator.

OBJECTIVE: To report repair of a right proximal tibial Salter-Harris type II fracture in a foal with a hybrid external fixator (HEF). STUDY DESIGN: Case report. ANIMALS: A 5-month-old male foal. METHODS: After open surgical reduction, an HEF built with wires, 2 half-rings, 3 half-threaded connecting rods, and Schanz pins was used to stabilize the fracture. RESULTS: Immediately after surgery, the foal had relatively good weight bearing. The HEF was removed at 60 days after radiographic confirmation of healing. CONCLUSIONS: HEF can be used to stabilize a proximal tibial Salter-Harris type II fracture in a 5-month-old foal. CLINICAL RELEVANCE: HEF should be considered as another option for repair of proximal tibial Salter-Harris type II fractures in foals.

Anti-Müllerian hormone and antral follicle count are more effective for selecting ewes with good potential for in vivo embryo production than the presence of FecGE mutation or eCG pre-selection tests.

This study aims to compare four different methods for selecting high responding sheep donors for in vivo embryo production. These methods include a pre-selection eCG test (eCG), antral follicle count (AFC), plasma anti-Müllerian hormone measurement (AMH) and genotyping for the presence of the FecGE mutation (a polymorphism in the GDF9 gene associated with increased ovulation rate). Santa Ines ewe lambs (n = 25) underwent superovulation (SOV) with 800 IU equine chorionic gonadotropin (eCG) and the corpus luteum (CL) count was recorded by laparoscopy after eight days. At the D0eCG, blood samples for AMH and genotyping analysis were collected. Twenty-one days after the end of the eCG test, the same animals underwent SOV with 200 mg of FSH, administered in six decreasing doses, and then naturally mated. Immediately before the beginning of the FSH protocol (D0FSH), and at the moment of the first FSH dose (D9FSH), the AFC was assessed. Plasma AMH was again determined at the D9FSH. After each screening process, animals were classified as having a high (HR), or low (LR), potential of response (using specific thresholds for each method). Then, the ewes' response to SOV and embryo yield for each screening method, classified as HR or LR, were compared. Animals classified as HR by AFC (HRAFC) and by AMH concentration (HRAMH) at the D9FSH, produced more viable embryos than those classified as LRAFC and LRAMH (HRAFC 6.2 ±â€¯3.2 vs LRAFC 2.8 ±â€¯3.0 and HRAMH 6.6 ±â€¯3.6 vs LRAMH 3.0 ±â€¯2.9). Pre-selection tests with eCG and different FecGE genotypes, either heterozygous (+/E) or wild type (+/+), were unable to discriminate HR or LR animals. A tendency (P = 0.06) to have lower plasma AMH was observed in heterozygous FecGE (+/E) ewes. In conclusion, both AFC and plasma AMH can be used to select donor ewes with a higher potential of response for in vivo embryo production.

Electrocardiographic evaluation of healthy dogs treated with ophthalmic solution of timolol maleate 0.5%: preliminary study / Avaliação eletrocardiográfica de cães clinicamente hígidos sob tratamento com solução oftálmica de maleato de timolol 0.5%: estudo preliminar

Timolol maleate 0.5% is a drug recommended for glaucoma treatment in dogs. After administration, it is absorbed to systemic circulation and being an antagonist of beta adrenergic receptors it has important systemic side effects on cardiac electrical conduction. The present study evaluated the modification caused by ophthalmic timolol 0.5% in the electrocardiogram. Six clinically normal dogs were selected to participate in two different ophthalmic treatments: in the first one, a placebo (hypromellose 0.5%) was used and in the second one, timolol 0.5% was administered. Each solution was applied twice a day, for 14 days. The electrocardiographic parameters were measured in times: zero, 10, 60, 120, 240, 360 and 720 min after ocular solution instillation in first, seventh and 14th days of each treatment. The differences found in electrocardiogram were more evident between 120 and 240 min after instillation of timolol 0.5% when compared with placebo treatment. The rhythm was irregular, with sinus arrhythmia and sinus bradycardia moments. The RR and PR intervals lengthen notoriously (p 0.05) from the first day of timolol administration, and are more expressive in the 14th day of treatment. The QT interval demonstrated a few changes, just lengthening noticeably (p 0.05) in the 14th day of timolol application. The QTc interval did not show expressive change. Despite the changes in the electrocardiogram, no clinical manifestation related to beta-adrenoceptor antagonists were observed. One must consider, however, that the animals studied were healthy and thus, clinical signs could result from the changes implied by the use of timolol in animals with pre-existing heart disease. Therefore, cardiac assessment of patients prior to prescription of ophthalmic timolol is recommended.

O maleato de timolol 0,5% é um fármaco recomendado para tratamento de glaucoma em cães. Após instilação, e absorvido para a circulação sistêmica e por ser um antagonista beta-adrenérgico pode promover efeitos colaterais sistêmicos importantes sobre a condução elétrica cardíaca. No presente estudo, foi avaliada a alteração causada pelo timolol 0,5% oftálmico no eletrocardiograma. Foram selecionados seis cães hígidos para participar de dois tratamentos oftálmicos diferentes: no primeiro foi instilado placebo (hipromelose 0,5%) e no segundo utilizou-se timolol 0,5%. O colírio foi instilado a cada 12 horas por 14 dias. Os parâmetros eletrocardiográficos foram mensurados nos tempos: zero, 10, 60, 120, 240, 360 e 720 minutos após instilação da solução ocular nos dias primeiro, sétimo e décimo quarto de cada tratamento. As alterações eletrocardiográficas foram mais evidentes entre 120 e 240 minutos pós-instilação de timolol 0,5% quando comparado com o tratamento placebo. O ritmo foi irregular, com momentos de arritmia sinusal e bradicardia sinusal. Os intervalos RR e PR prolongaram significativamente (p 0,05) desde o primeiro dia de instilação de timolol, sendo o prolongamento mais expressivo no décimo quarto dia de tratamento. O intervalo QT demonstrou pouca variação, apenas prolongando significativamente (p 0,05) no décimo quarto dia de aplicação de timolol. O intervalo QTc não demonstrou alteração significativa (p > 0,05). Apesar das alterações encontradas, não foram observadas manifestações clínicas relacionadas ao timolol nos animais estudados. Deve-se considerar, porém, que os animais em questão eram hígidos e, portanto, as alterações decorrentes do uso do timolol em animais com cardiopatias preexistentes poderiam promover sinais clínicos, sendo recomendada a avaliação cardíaca de pacientes previamente à prescrição do timolol oftálmico.

Parâmetros eletrocardiográficos de equinos Puro Sangue Árabe submetidos a exercício prolongado de enduro / Electrocardiographic parameters of Arabian horses submitted to prolonged exercise of endurance

Foram estabelecidos os parâmetros eletrocardiográficos de 20 equinos Puro Sangue Árabe em repouso e após exercício prolongado de enduro. A frequência cardíaca média foi de 35,85bpm em repouso, com predominância do ritmo sinusal, e de 53,78bpm, com taquicardia sinusal após o exercício. Como variação fisiológica, observou-se marcapasso migratório, e como não fisiológica, complexo ventricular prematuro. No pós-exercício, ocorreu aumento da amplitude das ondas P, R, S e T, com onda P tendendo a se tornar única em 35 por cento dos animais e bífida positiva em 65 por cento, e a onda T monofásica positiva. Houve redução da duração das ondas, dos intervalos e dos segmentos, e alongamento do QTc; porém, o complexo QRS quase não se alterou. O eixo elétrico, no plano frontal, apresentou desvios à direita e à esquerda em repouso sugestivo de aumento de câmara e hipertrofia secundárias ao treinamento, ao passo que, após o exercício, demonstrou desvio extremo para a direita, indicando alterações eletrolíticas. O escore cardíaco médio foi de 128,45ms, o que caracteriza os animais como atletas, sendo reduzido a 118,60ms após o exercício.

Electrocardiographic parameters of 20 Thoroughbred Arabian horses were established at rest and after prolonged endurance exercise. The mean heart rate was 35.85bpm at rest with predominant sinus rhythm, and 53.78bpm with sinus tachycardia after exercise. As physiological variation, wandering pacemaker was observed, and as non physiological, premature ventricular complex was noted. At post-exercise there was an increase of the amplitude of waves P, R, S and T, with P wave tending to become single in 35 percent of the animals and bifid positive in 65 percent, and with monophase positive T wave. There was a reduction in the duration of the waves, intervals and segments, and elongation of QTc, but the QRS complex hardly changed. The electrical axis in the frontal plane showed deviations to the right and to the left at rest, suggesting chamber enlargement and hypertrophy secondary to training, while after the exercise it showed extreme deviation to the right, indicating electrolyte imbalances. The average heart score was 128.45ms, which features the animals as athletes, being reduced to 118.60ms after exercise.